Search research articles
Contact Us
Filters
Showing results (171-180 of 242) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1996
Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4
J N Myers, S Yasumura, Y Suminami, et al.
Human Immunology
|
February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2
H J Zeh, G H Leder, M T Lotze, et al.
Journal of Leukocyte Biology
|
August 17, 1999
Tumor's other immune targets: dendritic cells
C Esche, A Lokshin, G V Shurin, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues
E A Grimm, B M Vose, E W Chu, et al.
British Journal of Cancer
|
August 17, 2000
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins
G Pirtskhalaishvili, G V Shurin, C Esche, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1992
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma
M T Lotze, H J Zeh, E M Elder, et al.
The Journal of Experimental Medicine
|
April 1, 1996
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin
M J Maeurer, D Martin, W Walter, et al.
Cell Death and Differentiation
|
October 17, 2009
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R Kang, D Tang, N E Schapiro, et al.
Cell Death & Disease
|
October 24, 2014
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
R Kang, W Hou, Q Zhang, et al.
Human Gene Therapy
|
December 1, 1994
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12
L Zitvogel, H Tahara, Q Cai, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 242) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1996
Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4
J N Myers, S Yasumura, Y Suminami, et al.
Human Immunology
|
February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2
H J Zeh, G H Leder, M T Lotze, et al.
Journal of Leukocyte Biology
|
August 17, 1999
Tumor's other immune targets: dendritic cells
C Esche, A Lokshin, G V Shurin, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues
E A Grimm, B M Vose, E W Chu, et al.
British Journal of Cancer
|
August 17, 2000
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins
G Pirtskhalaishvili, G V Shurin, C Esche, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1992
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma
M T Lotze, H J Zeh, E M Elder, et al.
The Journal of Experimental Medicine
|
April 1, 1996
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin
M J Maeurer, D Martin, W Walter, et al.
Cell Death and Differentiation
|
October 17, 2009
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R Kang, D Tang, N E Schapiro, et al.
Cell Death & Disease
|
October 24, 2014
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
R Kang, W Hou, Q Zhang, et al.
Human Gene Therapy
|
December 1, 1994
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12
L Zitvogel, H Tahara, Q Cai, et al.
Page
of 25